Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to a specific transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document details a specific increase in American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly reports a transaction where Mr. D E Troy acquired 270.024 ADSs at a price of $47.45 per ADS following the re-investment of the dividend paid on October 4, 2012.
Investor Verification Points
- Verify the total number of ADSs held by Mr. D E Troy post-transaction.
- Confirm the dividend reinvestment terms for the GlaxoSmithKline Performance Share Plan.
- Check the market price of GSK ADSs on October 9, 2012, to validate the transaction price of $47.45.